Cryoport

Cryoport, Inc., established in 1999 and trading as NASDAQ: CYRX, is a global leader in temperature-controlled supply chain solutions for the life sciences industry. Headquartered in Brentwood, Tennessee, the company operates across 3 locations, providing advanced packaging, specialty logistics, biostorage, and cryogenic equipment managed via an informatics platform. Cryoport's primary focus is addressing the critical temperature-controlled supply chain needs of the cell and gene therapy market, while also serving the broader biopharmaceutical, animal health, and human reproductive medicine sectors. The company is recognized as the world's largest manufacturer of cryogenic storage systems and a leading life science-focused specialty courier globally.

With an employee range of 500 - 1,000 individuals, Cryoport supports biopharmaceutical companies, universities, research institutions, and government agencies worldwide. Its robust infrastructure and advanced technology ensure the integrity of sensitive biological materials throughout transit, facilitating critical medical treatments and research. For insights into the people driving these specialized operations, one can Meet Cryoport's team. This dedication to specialized logistics and cold chain management is paramount for clients requiring absolute reliability and compliance for their high-value, temperature-sensitive shipments.

The company generated $182.9M in revenue, underscoring its significant market presence. Cryoport competes by offering specialized solutions that differentiate it from general freight providers. Its commitment to innovation in temperature-controlled transportation and storage is vital for clients entrusting them with life-saving therapies. This focus on expertise and advanced capabilities solidifies Cryoport's role in facilitating global medical breakthroughs and ensuring the safe, compliant delivery of critical biological materials.